Zobrazeno 1 - 10
of 13
pro vyhledávání: '"IV Paramonov"'
Autor:
EN Zotina, IV Paramonov, NV Minaeva, SV Samarina, Gritsaev Sv, Transfusiology, ya Sovetskaya str., Saint Petersburg, Russian Federation, EL Nazarova, Transfusiology, Krasnoarmeiskaya str., Kirov, Russian Federation
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 1, Pp 68-72 (2018)
Aim. To assess the prognostic value of clinical and hematological parameters used by hematologists for risk stratification in diffuse large B-cell lymphoma (DLBCL), and to justify the need for discovering new prognostic factors. Methods. The trial in
Autor:
NV Minaeva, Transfusiology, ya Sovetskaya str., Saint Petersburg, Russian Federation, E. V. Vaneeva, IV Paramonov, Gritsaev Sv, SV Samarina, AS Luchinin, Transfusiology, Krasnoarmeiskaya str., Kirov, Russian Federation, V. A. Rosin, D.A. Dyakonov
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 4, Pp 385-390 (2019)
Aim. To develop an integrated prognostic model of diffuse large B-cell lymphoma (DLBCL) on the basis of immunohis-tochemical tumor subtype and parameters of International Prognostic Index (IPI). Materials & Methods. Out of 104 DLBCL patients in the d
Autor:
Transfusiology, Krasnoarmeiskaya str., Kirov, Russian Federation, AS Luchinin, IV Paramonov, SV Semochkin, NM Pozdeev, NV Minaeva
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 2, Pp 175-181 (2018)
Aim. To assess prognostic value of surrogate clinical and laboratory markers in current therapy of multiple myeloma (MM). Materials & Methods. The analysis included 567 patients (215 men and 352 women), the Kirov region inhabitants with newly diagnos
Autor:
M.N. Khorobrykh, N. A. Zorina, V. I. Shardakov, EL Nazarova, IV Paramonov, NV Minaeva, E. E. Sukhorukova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 1, Pp 54-69 (2018)
Aim. To determine the value of polymorphisms of the immune response genes for the treatment efficacy in MM patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation (autoHSCT). Methods. The overall of 20 ММ pa
Autor:
Butina EV; Federal State Budget Institution of Science 'Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency'., Yovdiy AV; Federal State Budget Institution of Science 'Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency'., Poponina EA; Federal State Budget Institution of Science 'Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency'., Smolnikova MV; Federal State Budget Institution of Science 'Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency'., Sherstnev FS; Federal State Budget Institution of Science 'Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency'., Paramonov IV; Federal State Budget Institution of Science 'Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency'.
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2022 Sep 12; Vol. 67 (9), pp. 504-506.
Autor:
Butina EV; Federal State Budget Institution of Science «Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency»., Sherstnev FS; Federal State Budget Institution of Science «Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency»., Maksimov OD; Federal State Budget Institution of Science «Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency»., Yovdiy AV; Federal State Budget Institution of Science «Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency»., Paramonov IV; Federal State Budget Institution of Science «Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical-Biological Agency».
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2022 May 21; Vol. 67 (5), pp. 292-295.
Autor:
Loginova MA; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Kutyavina SS; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Smirnova DN; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Cheranev VV; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Paramonov IV; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation.
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2019; Vol. 64 (4), pp. 243-249.
Autor:
Cheranev VV; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Loginova MA; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Kutyavina SS; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Smirnova DN; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Zorina NA; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Minaeva NV; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Paramonov IV; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation.
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2019; Vol. 64 (12), pp. 762-768.
Autor:
Loginova MA; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation., Pavlov AE; Parseq Lab, Saint-Petersburg, 197350, Russian Federation., Zaytseva MA; Parseq Lab, Saint-Petersburg, 197350, Russian Federation., Simakova TS; Parseq Lab, Saint-Petersburg, 197350, Russian Federation., Pilshchikova NS; Parseq Lab, Saint-Petersburg, 197350, Russian Federation., Paramonov IV; FSBIS Kirov scientific-research institute of hematology and blood transfusion of FMBA of Russia, Kirov, 610027, Russian Federation.
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2018; Vol. 63 (12), pp. 788-792.
Autor:
Loginova MA; The The Russian medical R&D production center 'Rosplasma' of the Federal medical biological agency of Russia, 610027, Kirov, Russia.; The Kirovskii research institute of hematology and blood transfusion of the Federal medical biological agency of Russia, 610027, Kirov, Russia., Paramonov IV; The Kirovskii research institute of hematology and blood transfusion of the Federal medical biological agency of Russia, 610027, Kirov, Russia., Khalzov KV; The Novosibirskii center of blood, 630054, Novosibirsk, Russia., Moor YV; The Novosibirskii center of blood, 630054, Novosibirsk, Russia.
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2016; Vol. 61 (7), pp. 422-428.